NCT05782283 - A Study to Detect Advanced Liver Disease Via AI-enabled Electrocardiogram | Biotech Hunter

Enrollment

279

Participants

Timeline

Start Date

April 18, 2023

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions

Cirrhosis

Interventions

DEVICE

ACE (AI-Cirrhosis-ECG) 2.0

An electrocardiogram (ECG) based artificial intelligence (AI) powered tool for detection of undiagnosed cirrhosis in primary care practices. And email alert is sent to providers which will display whether the ACE 2.0 result is positive or negative for the likelihood of advanced liver disease.

Trial Locations (1)

55905

Mayo Clinic Minnesota, Rochester